Vertex Pharmaceuticals (VRTX) Shares Issued (2009 - 2026)

Vertex Pharmaceuticals has reported Shares Issued for 18 years, with the latest figure at $27.0 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Issued rose 61.68% year-over-year to $27.0 million; the trailing twelve-month figure through Mar 2026 stood at $138.0 million (up 20.63% YoY), and the FY2025 full-year result was $127.7 million, up 11.43% from the prior year.
• Shares Issued for Q1 2026 stood at $27.0 million, down from $54.0 million in the prior quarter.
• The five-year high for Shares Issued was $64.4 million in Q2 2022, with the low at $7.9 million in Q3 2025.
• Average Shares Issued over 5 years is $34.7 million, with a median of $34.3 million recorded in 2024.
• Year-over-year, Shares Issued surged 165.22% in 2022 and sank 57.92% in 2023.
• Tracing VRTX's Shares Issued over 5 years: stood at $51.6 million in 2022, then declined by 10.08% to $46.4 million in 2023, then retreated by 26.08% to $34.3 million in 2024, then soared by 57.43% to $54.0 million in 2025, then slumped by 50.0% to $27.0 million in 2026.
• The last three Shares Issued figures came in at $27.0 million (Q1 2026), $54.0 million (Q4 2025), and $7.9 million (Q3 2025), per Business Quant data.

Peer Comparison